Every Peptide Hormone Your Gut Produces

Motilin

20+ peptide hormones

The gastrointestinal tract produces over 20 peptide hormones from specialized enteroendocrine cells, making it the largest endocrine organ in the body.

Rehfeld, Physiological Reviews, 1998; Gribble & Reimann, Nature Reviews Endocrinology, 2019

Rehfeld, Physiological Reviews, 1998; Gribble & Reimann, Nature Reviews Endocrinology, 2019

View as image

Your gastrointestinal tract is the largest endocrine organ in your body. Scattered among the absorptive and secretory cells lining the gut are approximately 12 types of enteroendocrine cells that collectively produce over 20 peptide hormones. These hormones coordinate digestion, regulate appetite, control blood glucose, modulate gut motility, and communicate with the brain through the gut-brain axis. The motilin system that drives interdigestive cleaning waves is just one node in this network. Every meal triggers a cascade of peptide signals that determine how food is processed, how nutrients are absorbed, and when you stop eating. This guide catalogs every major gut peptide hormone, where it is produced, what it does, and why it matters.

The Appetite Hormones

Ghrelin: The Hunger Signal

Produced by: X/A-like cells in the gastric fundus | Receptor: GHS-R1a | Size: 28 amino acids

Ghrelin is the only known gut peptide that increases appetite. Identified in 1999 by Kojima et al. as an endogenous ligand for the growth hormone secretagogue receptor, ghrelin levels rise before meals and fall after eating.^[1] It is unique among gut peptides in requiring acylation (addition of an octanoyl group) by the enzyme GOAT for biological activity. Beyond appetite stimulation, ghrelin promotes gastric motility, stimulates growth hormone release, and modulates reward pathways in the brain. Its structural and functional relationship with motilin led researchers to classify them as members of the same peptide family.^[2] Ghrelin's role in gut motility extends well beyond hunger signaling.

Cholecystokinin (CCK): The Satiety Signal

Produced by: I-cells in the duodenum and jejunum | Receptor: CCK1 (gut), CCK2 (brain) | Size: Multiple forms (8-58 amino acids)

CCK was the first gut peptide shown to reduce food intake. Released within minutes of fat and protein entering the duodenum, CCK stimulates gallbladder contraction, pancreatic enzyme secretion, and sphincter of Oddi relaxation. Through CCK1 receptors on vagal afferents, it signals satiety to the brainstem, reducing meal size.^[3] CCK exists in multiple molecular forms produced by differential processing of the same precursor, with CCK-8 (sulfated octapeptide) being the most biologically active form. CCK's role as the brain's fullness signal operates on a meal-to-meal timescale, providing acute satiation rather than long-term appetite regulation.

Peptide YY (PYY): The "Ileal Brake"

Produced by: L-cells in the ileum and colon | Receptor: Y2 receptor | Size: 36 amino acids

PYY is released postprandially in proportion to caloric intake, with peak levels 1-2 hours after a meal. The active form, PYY(3-36), acts as the "ileal brake," slowing gastric emptying, reducing intestinal motility, and decreasing pancreatic secretion when nutrients reach the distal gut. Through Y2 receptors in the hypothalamic arcuate nucleus, PYY(3-36) suppresses appetite. PYY is co-secreted with GLP-1 from the same L-cells, and the two hormones work in concert to terminate feeding.

GLP-1: The Incretin That Changed Medicine

Produced by: L-cells in the ileum and colon | Receptor: GLP-1R | Size: 30-31 amino acids

Glucagon-like peptide-1 is processed from the proglucagon gene in intestinal L-cells (the same gene produces glucagon in pancreatic alpha cells, but tissue-specific processing yields different peptides). GLP-1 potentiates glucose-dependent insulin secretion (the "incretin effect"), suppresses glucagon release, slows gastric emptying, and reduces appetite through both peripheral and central mechanisms.

GLP-1's half-life in circulation is approximately 2 minutes due to rapid degradation by dipeptidyl peptidase-4 (DPP-4). This limitation drove the development of DPP-4 resistant analogs: semaglutide, liraglutide, and dulaglutide for diabetes and obesity. The complete GLP-1 receptor agonist class now represents one of the most commercially significant drug categories in medicine, all derived from understanding this single gut peptide.

GIP: The Other Incretin

Produced by: K-cells in the duodenum and jejunum | Receptor: GIPR | Size: 42 amino acids

Glucose-dependent insulinotropic peptide (originally called gastric inhibitory peptide) is the other major incretin hormone. GIP is unique among gut hormones in responding to all three macronutrient types: glucose, amino acids, and fatty acids. Like GLP-1, GIP potentiates glucose-dependent insulin secretion. Unlike GLP-1, GIP also stimulates glucagon secretion during hypoglycemia and promotes fat storage in adipose tissue. The dual GIP/GLP-1 receptor agonist tirzepatide exploits both incretin pathways simultaneously.

The Digestive Secretion Hormones

Gastrin: The Acid Controller

Produced by: G-cells in the gastric antrum and duodenum | Receptor: CCK2/gastrin receptor | Size: Multiple forms (14-34 amino acids)

Gastrin stimulates hydrochloric acid secretion from parietal cells, pepsinogen release from chief cells, and growth of gastric mucosa. It is released in response to stomach distension, vagal stimulation, and the presence of amino acids and peptides in the gastric lumen. Gastrin exists in three major forms: G-34 (big gastrin), G-17 (little gastrin, the predominant form), and G-14 (mini-gastrin). The relationship between secretin and gastrin represents one of the oldest known examples of hormonal counter-regulation in physiology.

Secretin: The First Hormone Ever Discovered

Produced by: S-cells in the duodenum | Receptor: Secretin receptor (class B GPCR) | Size: 27 amino acids

Secretin holds a singular place in endocrinology: it was the first substance identified as a hormone, by Bayliss and Starling in 1902. Released when acidic chyme enters the duodenum, secretin stimulates bicarbonate-rich pancreatic secretion to neutralize gastric acid, inhibits gastric acid production, and promotes bile secretion from the liver. Secretin belongs to the same peptide family as VIP, GIP, glucagon, and GLP-1, all of which share structural homology.

Motilin: The Housekeeper

Produced by: M-cells in the duodenum and jejunum | Receptor: Motilin receptor (GPR38) | Size: 22 amino acids

Motilin drives the migrating motor complex (MMC), the cyclical pattern of strong contractions that sweeps undigested material through the small intestine during fasting. MMC cycles occur every 90-120 minutes between meals and are disrupted by feeding. Motilin and ghrelin are structural relatives, sharing approximately 36% amino acid sequence identity, and their receptors share approximately 52% homology.^[2] Erythromycin, a macrolide antibiotic, is a motilin receptor agonist, which is why it is sometimes used to treat gastroparesis.^[4]

The Neuroendocrine Regulators

VIP (Vasoactive Intestinal Peptide): The Master Regulator

Produced by: Neurons throughout the enteric nervous system | Receptor: VPAC1, VPAC2 | Size: 28 amino acids

VIP is technically a neuropeptide rather than a classical gut hormone: it is produced by enteric neurons rather than enteroendocrine cells. It relaxes smooth muscle (causing vasodilation and reducing gut motility), stimulates water and electrolyte secretion into the intestinal lumen, and inhibits gastric acid production. VIP also has immunomodulatory and anti-inflammatory properties. Excessive VIP production by rare tumors (VIPomas) causes profuse watery diarrhea. VIP's role as the gut's master regulator extends to the nervous, immune, and cardiovascular systems.^[5]

Somatostatin: The Universal Brake

Produced by: D-cells throughout the gut, pancreas, and hypothalamus | Receptor: SSTR1-5 | Size: 14 or 28 amino acids

Somatostatin is the inhibitory counterpart to virtually every stimulatory gut hormone. It suppresses gastrin, CCK, secretin, GIP, motilin, and VIP release. It inhibits gastric acid, pancreatic enzyme, and bile secretion. It reduces intestinal motility and blood flow. Somatostatin also inhibits insulin, glucagon, and growth hormone release. The synthetic somatostatin analog octreotide is used clinically to treat conditions involving hormone excess, including carcinoid syndrome, acromegaly, and VIPomas.

GLP-2: The Gut Repair Factor

Produced by: L-cells in the ileum and colon (co-secreted with GLP-1) | Receptor: GLP-2R | Size: 33 amino acids

GLP-2 is the intestinal trophic factor: it promotes growth and repair of the intestinal mucosa, increases villus height, enhances nutrient absorption, and reduces intestinal permeability. Unlike its co-secreted partner GLP-1, GLP-2 has no significant effects on insulin secretion or appetite. The GLP-2 analog teduglutide is FDA-approved for short bowel syndrome, where it reduces the need for parenteral nutrition by promoting intestinal adaptation. GLP-2's gut repair capabilities make it one of the most therapeutically promising gut peptides beyond the incretin class.

Neurotensin: The Fat Sensor

Produced by: N-cells in the ileum | Receptor: NTS1, NTS2 | Size: 13 amino acids

Neurotensin is released primarily in response to fat ingestion. It slows gastric emptying, stimulates pancreatic and biliary secretion, and promotes intestinal growth. Neurotensin is co-expressed with GLP-1 and PYY in L-cells, and its release pattern mirrors postprandial lipid absorption. Elevated fasting neurotensin levels are associated with increased risk of metabolic syndrome and cardiovascular disease in epidemiological studies.

Substance P and CGRP: The Sensory Peptides

The gut also produces sensory neuropeptides including substance P (11 amino acids) and calcitonin gene-related peptide (CGRP, 37 amino acids) from sensory nerve endings. These peptides mediate pain signaling, neurogenic inflammation, and local blood flow regulation in the gut wall. They are not classical gut hormones but participate in the peptide signaling network that coordinates digestion with immune and vascular responses.

How the System Works Together

No gut peptide operates in isolation. A single meal triggers a coordinated cascade:

1. Cephalic phase: Vagal stimulation releases gastrin (acid production) before food arrives
2. Gastric phase: Stomach distension and protein trigger more gastrin; ghrelin secretion falls
3. Duodenal phase: Acid triggers secretin (bicarbonate); fat and protein trigger CCK (enzymes, gallbladder) and GIP (insulin)
4. Ileal phase: Nutrients reaching the distal gut trigger GLP-1, PYY, GLP-2, and neurotensin from L-cells
5. Interdigestive phase: After absorption completes, motilin drives the MMC to clear residual material

Throughout this sequence, somatostatin acts as a brake on each stimulatory signal, preventing overshoot. The entire process involves peptides acting through three parallel pathways: endocrine (bloodstream delivery to distant targets), paracrine (local diffusion to neighboring cells), and neural (vagal afferent signaling to the brainstem).

Modern single-cell transcriptomics has revealed that individual enteroendocrine cells are more versatile than previously recognized. A single L-cell can produce GLP-1, PYY, GLP-2, neurotensin, and CCK simultaneously. The traditional model assigning one hormone to one cell type is being replaced by a continuum model where cells express overlapping hormone profiles depending on their location along the gut and their developmental state.

The Bottom Line

The gastrointestinal tract produces over 20 peptide hormones from specialized enteroendocrine cells constituting less than 1% of the gut epithelium. These hormones control digestion (gastrin, secretin, CCK, motilin), appetite (ghrelin, CCK, PYY, GLP-1), metabolism (GLP-1, GIP), gut repair (GLP-2), and motility (VIP, motilin, somatostatin). Ghrelin is the only appetite-stimulating gut peptide; all satiety signals are inhibitory. GLP-1, the target of the semaglutide drug class, is just one node in this interconnected network. Single enteroendocrine cells can produce multiple hormones, and the system operates through endocrine, paracrine, and neural signaling in parallel.

Frequently Asked Questions

How many peptide hormones does the gut produce?

The gastrointestinal tract produces over 20 distinct peptide hormones from at least 12 types of specialized enteroendocrine cells. The major ones include gastrin, secretin, CCK, GIP, motilin, GLP-1, GLP-2, PYY, ghrelin, neurotensin, somatostatin, and VIP. Despite making up less than 1% of the gut epithelium, these cells collectively make the GI tract the largest endocrine organ in the body.

What gut hormone makes you feel hungry?

Ghrelin is the only known gut peptide hormone that stimulates appetite. Produced by X/A-like cells in the stomach, ghrelin levels rise before meals and fall after eating. All other gut peptide hormones either suppress appetite (CCK, GLP-1, PYY) or have no direct effect on hunger. Ghrelin was discovered in 1999 by Kojima et al. as the endogenous ligand for the growth hormone secretagogue receptor.

What is the difference between GLP-1 and GIP?

Both are incretin hormones that enhance glucose-dependent insulin secretion after meals. GLP-1 is produced by L-cells in the ileum and colon, suppresses glucagon, slows gastric emptying, and reduces appetite. GIP is produced by K-cells in the duodenum and jejunum, responds to all three macronutrient types, and can stimulate glucagon during hypoglycemia. GIP also promotes fat storage. The drug tirzepatide activates both receptors simultaneously for enhanced metabolic effects.

What is the incretin effect?

The incretin effect is the observation that oral glucose stimulates 50-70% more insulin secretion than the same amount of glucose delivered intravenously. This additional insulin release is driven by gut peptide hormones, primarily GLP-1 and GIP, released from enteroendocrine cells when nutrients contact the intestinal lining. The incretin effect is diminished in type 2 diabetes, which is why GLP-1 receptor agonists are effective diabetes treatments.

What does CCK do in the gut?

Cholecystokinin (CCK) is released from I-cells in the duodenum when fat and protein enter the small intestine. It contracts the gallbladder to release bile, stimulates pancreatic digestive enzyme secretion, relaxes the sphincter of Oddi, slows gastric emptying, and signals satiety to the brain through vagal nerve afferents. CCK was the first gut peptide shown to reduce food intake and acts on a meal-to-meal timescale.

Is the gut really an endocrine organ?

The gastrointestinal tract is the largest endocrine organ in the body by total hormone output. Its enteroendocrine cells produce over 20 peptide hormones that regulate not only digestion but also appetite, blood glucose, gut repair, immune function, and brain signaling through the gut-brain axis. Modern single-cell studies show individual enteroendocrine cells can produce multiple hormones simultaneously, making them more complex than most traditional endocrine glands.